Literature DB >> 7250145

Pharmacokinetics of fenclofenac following single and multiple doses.

R Henson, J G Lloyd-Jones, J D Nichols, B J Jordan.   

Abstract

The plasma concentration of the anti-inflammatory drug fenclofenac was investigated in volunteers following single oral doses of 200, 500 and 600 mg, as well as multiple doses of 600mg b.i.d. over five days, using gas chromatography with electron capture detection. The pharmacokinetic parameters derived were independent of dose, and the terminal half-life, t1/2, varied independently of dose between 20 and 38 hours (27.23 +/- 1.8 at 600mg). The apparent volume of distribution (Vd area) had similar values at doses of 200, 500 and 600mg of 15.2 +/- 2.6, 18.2 +/- 1.5 and 14.7 +/- 1.7 litres respectively. These small volumes of distribution indicate that fenclofenac distributes mainly into extracellular space. A mean peak plasma concentration of 63.5 +/- 4.6microgram/ml developed after 3 to4 hours following a single 600mg dose whilst a mean steady state plasma concentration (600mg b.i.d.) of 86.9 +/- 5.7 microgram/ml was achieved within four days, and this decayed with a mean terminal half-life of 25.9 +/- 4.2 hours.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7250145     DOI: 10.1007/BF03189467

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The methodology of the fenclofenac clinical research programme and results obtained with particular reference to the therapeutic dose range.

Authors:  R Tudor; A A Goldberg; D R Clarke
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

Review 4.  Hepatic vascular bed.

Authors:  C V Greenway; R D Stark
Journal:  Physiol Rev       Date:  1971-01       Impact factor: 37.312

5.  Preliminary studies of absorption and excretion of benoxaprofen in man.

Authors:  G L Smith; R A Goulbourn; R A Burt; D H Chatfield
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

6.  Reversal of yeast-induced motor impairment in rats as a test for narcotic and non-narcotic analgesics.

Authors:  D C Atkinson; A Cowan
Journal:  J Pharm Pharmacol       Date:  1974-09       Impact factor: 3.765

7.  Anti-inflammatory and related properties of 2-(2,4-dichlorophenoxy)phenylacetic acid (fenclofenac).

Authors:  D C Atkinson; E C Leach
Journal:  Agents Actions       Date:  1976-09

8.  2-(2,4-dichlorophenoxy) phenylacetic acid (fenclofenac): one of a novel series of anti-inflammatory compounds with low ulcerogenic potential.

Authors:  D C Atkinson; K E Godfrey; B J Jordan; E C Leach; B Meek; J D Nichols; J F Saville
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

9.  Clofibrate kinetics after single and multiple doses.

Authors:  R Gugler; J Hartlapp
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

  9 in total
  3 in total

1.  Pharmacokinetics of fenclofenac in children with juvenile rheumatoid arthritis.

Authors:  A L Mäkelä; M Scheinin; E Iisalo; J S Salonen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Michaelis-Menten absorption kinetics in drugs: - examples and implications.

Authors:  J H Wood; K M Thakker
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.